|
LA PROVINCIA QUINTUPLICARÍA EL APOYO EN SALUD A ROSARIO - info341.com.ar |
... de las drogas oncológicas, las dialisis crónicas, de la derivación de pacientes a efectores privados en aquellos casos que no pueden ser atendidos en ... read more |
|
Nephros Provides Corporate Update - MarketWatch |
"Physician interest in the Nephros ESRD products continues to be strong; the 510k submission for FDA approval of Nephros's products represents an important ... read more |
Fresenius kaufen - AktienCheck |
Wie sich im Rahmen der Q3-Berichterstattung gezeigt habe, habe die Übernahme des amerikanischen Herstellers für IV-Generika APP das Ergebnis der Fresenius ... read more |
Affymax Announces Another Favorable Data Monitoring Committee ... - PR-Inside.com (Pressemitteilung) |
In the Phase 3 program, Hematide is being evaluated to treat anemia in chronic renal failure patients on dialysis and not on dialysis. ... read more |
Market Report -- In Play (AFFY) - MSN Money |
Affymax announces another 'favorable' data monitoring committee review of Phase 3 hematide program Co announces that the independent Data Monitoring ... read more |
|
|
|
<< Start < Prev 2621 2622 2623 2624 2625 2626 2627 2628 2629 2630 Next > End >>
|
Page 2627 of 2630 |